Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
Seminars in Vascular Medicine|August 27, 2005
A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatranStefan C Carlsson, Sam Schulman
Tuberculosis and Respiratory Diseases|October 9, 2013
Respiratory review of 2013: pulmonary thromboembolismHun Gyu Hwang, Sam Schulman
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 15, 2009
Dabigatran etexilate: future directions in anticoagulant treatmentSam Schulman, Paul A Reilly
Blood|February 4, 2012
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switchSam Schulman, Mark A Crowther
Journal of Thrombosis and Thrombolysis|March 23, 2018
Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective studySiavash Piran, Caroline Gabriel, Sam Schulman
Regional Anesthesia and Pain Medicine|September 24, 2016
Reply to Dr Lessire et alJames Douketis, Sam Schulman, Summer Syed
Thrombosis Research|April 13, 2016
Management of bleeding complications in patients with cancer on DOACsSam Schulman, Jeffrey Shrum, Ammar Majeed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 2003
Acquired hemophilia masked by warfarin therapy: report on two casesBertil Uggla, Olle Linder, Sam Schulman
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activityAnna Agren, Björn Wiman, Sam Schulman
Seminars in Vascular Medicine|August 27, 2005
Ximelagatran in the clinic: practical management of patientsSam Schulman, Gregory Y H Lip
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
Seminars in Vascular Medicine|August 27, 2005
A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatranStefan C Carlsson, Sam Schulman
Tuberculosis and Respiratory Diseases|October 9, 2013
Respiratory review of 2013: pulmonary thromboembolismHun Gyu Hwang, Sam Schulman
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 15, 2009
Dabigatran etexilate: future directions in anticoagulant treatmentSam Schulman, Paul A Reilly
Blood|February 4, 2012
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switchSam Schulman, Mark A Crowther
Journal of Thrombosis and Thrombolysis|March 23, 2018
Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective studySiavash Piran, Caroline Gabriel, Sam Schulman
Regional Anesthesia and Pain Medicine|September 24, 2016
Reply to Dr Lessire et alJames Douketis, Sam Schulman, Summer Syed
Thrombosis Research|April 13, 2016
Management of bleeding complications in patients with cancer on DOACsSam Schulman, Jeffrey Shrum, Ammar Majeed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 2003
Acquired hemophilia masked by warfarin therapy: report on two casesBertil Uggla, Olle Linder, Sam Schulman
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activityAnna Agren, Björn Wiman, Sam Schulman
Seminars in Vascular Medicine|August 27, 2005
Ximelagatran in the clinic: practical management of patientsSam Schulman, Gregory Y H Lip
Pageof 31